STUDIO

SPERMOSENS PRESENTATION

BioStock Investor Pitch: Spermosens

Swedish Spermosens’ vision is to improve diagnostics within the area of male infertility and thus help improve IVF treatments. Using the company’s JUNO-Checked system...

RECOMMENDED READING

RhoVac acquires Chosa Oncology

RhoVac becomes Chosa Oncology after acquisition

After last year´s disappointing phase IIb-readout, a lot has happened for Lund based biotech...
SynAct

SynAct Pharma’s acquisition of TXP Pharma concluded

Just before the end of 2022, SynAct Pharma announced its plans to acquire the...

EVENT